T1	Participants 596 699	patients who had undergone a CT scan and had suspected stage I to IIIA lung cancer, from six UK centres
T2	Participants 1701 1776	randomly allocated 133 patients to treatment: 66 to EBUS-TBNA and 67 to CDS
T3	Participants 2347 2355	patients